Mercer Global Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.81M | Buy |
119,992
+14,405
| +14% | +$1.06M | 0.02% | 393 |
|
|
2025
Q1 | $12.1M | Buy |
105,587
+15,884
| +18% | +$1.81M | 0.03% | 318 |
|
|
2024
Q4 | $4.52M | Sell |
89,703
-71
| -0.1% | -$3.58K | 0.01% | 568 |
|
|
2024
Q3 | $4.2M | Buy |
89,774
+7,973
| +10% | +$373K | 0.01% | 544 |
|
|
2024
Q2 | $2.66M | Buy |
81,801
+10,658
| +15% | +$346K | 0.01% | 639 |
|
|
2024
Q1 | $1.79M | Sell |
71,143
-3,537
| -5% | -$89.1K | 0.01% | 753 |
|
|
2023
Q4 | $2.43M | Buy |
74,680
+7,387
| +11% | +$240K | 0.01% | 674 |
|
|
2023
Q3 | $1.83M | Buy |
67,293
+14,644
| +28% | +$399K | 0.01% | 738 |
|
|
2023
Q2 | $1.17M | Buy |
52,649
+7,459
| +17% | +$166K | ﹤0.01% | 893 |
|
|
2023
Q1 | $979K | Buy |
45,190
+3,326
| +8% | +$72.1K | ﹤0.01% | 921 |
|
|
2022
Q4 | $850K | Buy |
41,864
+799
| +2% | +$16.2K | ﹤0.01% | 982 |
|
|
2022
Q3 | $1.05M | Buy |
41,065
+3,285
| +9% | +$84.2K | 0.01% | 824 |
|
|
2022
Q2 | $898K | Buy |
37,780
+4,817
| +15% | +$114K | 0.01% | 894 |
|
|
2022
Q1 | $742K | Buy |
32,963
+6,760
| +26% | +$152K | ﹤0.01% | 1033 |
|
|
2021
Q4 | $519K | Buy |
26,203
+2,964
| +13% | +$58.7K | ﹤0.01% | 1183 |
|
|
2021
Q3 | $457K | Buy |
23,239
+1,445
| +7% | +$28.4K | ﹤0.01% | 1208 |
|
|
2021
Q2 | $479K | Buy |
21,794
+1,543
| +8% | +$33.9K | ﹤0.01% | 1162 |
|
|
2021
Q1 | $482K | Buy |
20,251
+2,145
| +12% | +$51.1K | ﹤0.01% | 1094 |
|
|
2020
Q4 | $474K | Buy |
18,106
+2,685
| +17% | +$70.3K | 0.01% | 884 |
|
|
2020
Q3 | $268K | Buy |
15,421
+3,222
| +26% | +$56K | ﹤0.01% | 1001 |
|
|
2020
Q2 | $205K | Buy |
+12,199
| New | +$205K | ﹤0.01% | 995 |
|